Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

DSM-III disorders from age 11 to age 15 years.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Syringomyelia coexisting with guillain-barre syndrome.
Autoimmune neurological disorders associated with group-A beta-hemolytic streptococcal infection.
Suicidal Behavior and Neurological Illnesses.
Poppers toxic maculopathy misdiagnosed as atypical optic neuritis.
Leukoencephalopathy due to Oral Methotrexate.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Endotoxin-induced systemic inflammation activates microglia: [(11)C]PBR28 positron emission tomography in nonhuman primates.
RANDOM FOREST FLAIR RECONSTRUCTION FROM T 1, T 2, AND PD -WEIGHTED MRI.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Internet-delivered lifestyle physical activity intervention improves body composition in multiple sclerosis: Preliminary evidence from a randomized controlled trial.
Alemtuzumab and multiple sclerosis: Is it safe?
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
New hope for multiple sclerosis patients.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
A concise synthesis of Fingolimod: an orally available drug for treating multiple sclerosis.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis.
NAD(+) protects against EAE by regulating CD4(+) T-cell differentiation.
Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
The p38α mitogen-activated protein kinase is a key regulator of myelination and remyelination in the CNS.
Efficacy and tolerability of different brands of intravenous immunoglobulin in the maintenance treatment of chronic immune mediated neuropathies.
[Current possibilities of the comprehensive diagnostic assessment in the differential diagnosis of inflammation and tumors of the spine cord.]

Pages